ProstaMax 20 mg

ProstaMax for research: identity and specifications

ProstaMax is a short synthetic peptide of the Khavinson class of peptide bioregulators, studied in preclinical models of tissue-specific gene expression and cell signaling. Supplied as a 20 mg vial of lyophilized powder, with no fillers, carriers or excipients, at ≥98% purity by HPLC, produced by solid-phase synthesis and purified under analytical controls documented for each lot.

Scientific background

Short peptide bioregulators were developed by the research group of Prof. Vladimir Khavinson, and have been investigated for a hypothesized ability to interact with DNA and to modulate gene expression in cell-specific ways. In experimental models, ProstaMax is examined in work on prostate tissue-related signaling and on the regulation of peptide-dependent cellular pathways.

The literature on this class is largely preclinical and in vitro, and is used in basic studies of cell signaling, transcription-factor activity and tissue aging, always under controlled bench conditions and without extrapolating results to human or veterinary use.

• Short-peptide bioregulator activity in cell culture
• Prostate-related cell signaling in experimental models
• Peptide interactions with regulatory pathways in controlled systems
• Gene expression and transcription-factor activity studies

Technical specifications

Analytical quality and chain of custody

Every lot of ProstaMax is synthesized in registered facilities, with independent analytical verification by third-party laboratories and full chain-of-custody documentation. The certificate of analysis (COA) for each lot can be reviewed before purchase, recording HPLC purity and the other quality-control parameters used to release the material.

Reconstitution and laboratory handling

As a bench procedure, the lyophilized vial is reconstituted with a known volume of a suitable solvent, added along the inner wall of the vial, followed by gentle swirling until fully dissolved, without vigorous shaking. The reconstituted solution should be kept refrigerated and protected from light, and used in controlled assays within the stability period validated by the laboratory. Handling must be performed only by qualified personnel, in a bench environment suitable for in vitro experimentation, with lot number and storage conditions documented according to good laboratory practice.

Frequently asked questions

What is the purity of the ProstaMax supplied?

≥98% by HPLC, with the lot-specific value reported on the certificate of analysis (COA).

What kind of compound is ProstaMax?

ProstaMax is a short synthetic peptide belonging to the Khavinson class of peptide bioregulators. The lot COA documents the identity and purity of the supplied material.

How should the compound be stored?

At -20 °C, protected from light and moisture, as a lyophilized powder until reconstitution.

Does the certificate of analysis come with the lot?

Yes, every lot has a matching COA that can be verified before purchase using the button on this page.

Who can purchase ProstaMax?

Sales are restricted to qualified researchers and institutions, for laboratory use only, as detailed in the research-use-only notice on this page.

See the peptide reference guide and the page on how every lot is tested by HPLC and COA.

Research use only (RUO). This material is supplied for in vitro laboratory research only. It is not a drug, dietary supplement or cosmetic, and it is not intended for human or veterinary use, or for the diagnosis or treatment of any condition. Sales are restricted to researchers and institutions.